CA Patent

CA2129828A1 — Liposomal itraconazole formulations

Assigned to Janssen Cilag SpA · Expires 1993-08-19 · 33y expired

What this patent protects

The present invention relates to a topical liposomal formulation comprising itraconazole, a phospholipid, a solvent system for itraconazole and said phospholipid, water and conventional auxiliary formulating agents, and a method of preparing said formulation.

USPTO Abstract

The present invention relates to a topical liposomal formulation comprising itraconazole, a phospholipid, a solvent system for itraconazole and said phospholipid, water and conventional auxiliary formulating agents, and a method of preparing said formulation.

Drugs covered by this patent

Patent Metadata

Patent number
CA2129828A1
Jurisdiction
CA
Classification
—
Expires
1993-08-19
Drug substance claim
No
Drug product claim
No
Assignee
Janssen Cilag SpA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.